CClinicalTrials.gg
Status unknownNCT05696535Updated Jan 25, 2023

Investigation of the Relationship Between Lower and Upper Extremity Selective Motor Control and Sensory Functions in Children With Spastic Cerebral Palsy

An observational study in Spastic Cerebral Palsy, Motor Activity and Lower Extremity Problem, sponsored by Mustafa Kemal University. Status unknown. Open to participants aged 4 Years to 18 Years. Per ClinicalTrials.gov, last updated 2023-01-25.

Sponsored by Mustafa Kemal University · Observational

The sponsor has not verified this record recently (last verified Jan 2023), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
100
Ages
4 Years to 18 Years
Sex
All
01

Study summary

Although spasticity, contractures and muscle weakness in children with CP are disorders that can be observed more easily and are more focused and given more importance in evaluation and treatment approaches; Inadequate or loss of selective motor control negatively affects motor functions to a greater extent.

It is very important to reveal the causes and consequences of selective motor disability in children with spastic cerebral palsy, in terms of creating effective treatment plans.

The number of patients to participate in the study was determined as 100. The study will be carried out in Hatay Mustafa Kemal University Research and Application Hospital, Department of Pediatrics.

In our study, demographic information will be filled in, and lower extremity selective control assessment scale (SCALE) for lower extremity, upper extremity selective control scale (SCUES) for upper extremity, and sensory assessment (touch, two-point discrimination and proprioceptive sensory assessment) will be performed on the patients who accepted the study.

02

Conditions studied

  • Spastic Cerebral Palsy
  • Motor Activity
  • Lower Extremity Problem
  • Upper Extremity Problem
03

In context

Muscle Spasticity

704 studies on the registry are indexed under Muscle Spasticity; 149 are open to participants now.

This study's planned enrollment of 100 is above the median of 60 across 162 observational studies indexed under Muscle Spasticity.

Browse Muscle Spasticity studies →

Lead sponsor

Mustafa Kemal University is the lead sponsor of 71 studies on the registry; 18 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children with spastic cerebral palsy

Inclusion criteria

  • Giving consent to participate in the study
  • To be diagnosed with spastic type cerebral palsy;
  • Being between the ages of 4-18;
  • Being at level I-II-III according to the gross motor function classification system (GMFCS);
  • Not having undergone Botulinum Toxin injection/lower-upper extremity surgery in the last 6 months

Exclusion criteria

Exclusion criteria:

  • To be in level IV-V according to gross motor function classification system (GMFCS)
  • Having severe mental retardation who does not understand verbal commands
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
100 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Evaluation of selective motor control function

    Time frame: 2 months

Secondary outcomes

  1. The relationship between selective motor control and sensory functions

    Time frame: 3 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided — Data entry is planned as patients are included in the study and data are collected. A timetable has not been foreseen yet.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 25, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05696535
Lead sponsor
Mustafa Kemal University
Responsible party
Fırat Cicekli (Physiotherapist, Mustafa Kemal University) — Principal investigator
First posted
Jan 25, 2023
Start date
Jan 2023 (estimated)
Primary completion
Apr 2023 (estimated)
Completion
Jun 2023 (estimated)
Last update
Jan 25, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion